tiprankstipranks
Advertisement
Advertisement

TLSA Stock Latest News

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Receives FDA Clearance to Advance Lucid-MS Into Phase 2 Multiple Sclerosis Trial
TipRanks NewswireQuantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Receives FDA Clearance to Advance Lucid-MS Into Phase 2 Multiple Sclerosis Trial
13d ago
IMUX
QNTM
Tiziana Life Sciences CEO Ivor Elrifi purchases 321,423 shares
PremiumThe Fly
Tiziana Life Sciences CEO Ivor Elrifi purchases 321,423 shares
17d ago
TLSA
Tiziana Life Sciences CEO Increases Stake with Nasdaq Share Purchase
PremiumCompany Announcements
Tiziana Life Sciences CEO Increases Stake with Nasdaq Share Purchase
17d ago
6K
TLSA
Tiziana Life Sciences CEO Boosts Stake as Lead MS Therapy Progresses
PremiumCompany Announcements
Tiziana Life Sciences CEO Boosts Stake as Lead MS Therapy Progresses
19d ago
6K
TLSA
Tiziana Life Sciences Posts Reproducible PET Evidence of Reduced Brain Inflammation in Third MSA Patient
PremiumCompany Announcements
Tiziana Life Sciences Posts Reproducible PET Evidence of Reduced Brain Inflammation in Third MSA Patient
23d ago
6K
TLSA
Tiziana Life Sciences chairman Gabriele Cerrone purchases 42,357 shares at 99c
PremiumThe FlyTiziana Life Sciences chairman Gabriele Cerrone purchases 42,357 shares at 99c
1M ago
TLSA
Tiziana Life Sciences Chairman Boosts Stake to Nearly 35% in July Share Purchase
Premium
Company Announcements
Tiziana Life Sciences Chairman Boosts Stake to Nearly 35% in July Share Purchase
1M ago
6K
TLSA
Tiziana Life Sciences Completes Enrollment in Phase 2 INFORM-MS Trial for Intranasal Foralumab
Premium
Company Announcements
Tiziana Life Sciences Completes Enrollment in Phase 2 INFORM-MS Trial for Intranasal Foralumab
2M ago
6K
TLSA
Tiziana Life Sciences doses last patient in intranasal foralumab trial
PremiumThe Fly
Tiziana Life Sciences doses last patient in intranasal foralumab trial
2M ago
TLSA
Tiziana Life Sciences chairman Gabriele Cerrone purchases 15,000 shares
PremiumThe Fly
Tiziana Life Sciences chairman Gabriele Cerrone purchases 15,000 shares
2M ago
TLSA
Tiziana Life Sciences Chair Boosts Stake as Foralumab Trials Advance
PremiumCompany Announcements
Tiziana Life Sciences Chair Boosts Stake as Foralumab Trials Advance
2M ago
6K
TLSA
SpaceX targets IPO valuation of at least $1.8T, Bloomberg says
PremiumThe Fly
SpaceX targets IPO valuation of at least $1.8T, Bloomberg says
3M ago
TLSA
Tiziana Life Sciences to Showcase Intranasal Foralumab Progress at Jefferies Healthcare Conference
PremiumCompany AnnouncementsTiziana Life Sciences to Showcase Intranasal Foralumab Progress at Jefferies Healthcare Conference
3M ago
6K
TLSA
Tiziana Life Sciences Completes Enrollment in Phase 2 Intranasal Foralumab MS Trial
Premium
Company Announcements
Tiziana Life Sciences Completes Enrollment in Phase 2 Intranasal Foralumab MS Trial
3M ago
6K
TLSA
Tiziana fully enrolls Phase 2 placebo-controlled MS trial
Premium
The Fly
Tiziana fully enrolls Phase 2 placebo-controlled MS trial
3M ago
TLSA
Tiziana Life Sciences announces updated intranasal foralumab data
PremiumThe Fly
Tiziana Life Sciences announces updated intranasal foralumab data
3M ago
TLSA
Tiziana Life Sciences Reports Positive Expanded Access Data for Intranasal Foralumab in Progressive MS
PremiumCompany Announcements
Tiziana Life Sciences Reports Positive Expanded Access Data for Intranasal Foralumab in Progressive MS
3M ago
6K
TLSA
Tiziana Phase 2 trial for foralumab shows reduced brain inflammation
PremiumThe Fly
Tiziana Phase 2 trial for foralumab shows reduced brain inflammation
3M ago
TLSA
Tiziana Life Sciences Posts Early PET Data Showing Reduced Brain Inflammation in MSA Trial of Intranasal Foralumab
PremiumCompany Announcements
Tiziana Life Sciences Posts Early PET Data Showing Reduced Brain Inflammation in MSA Trial of Intranasal Foralumab
3M ago
6K
TLSA
Tiziana Life Sciences Delays Annual 20-F Filing
PremiumCompany AnnouncementsTiziana Life Sciences Delays Annual 20-F Filing
4M ago
TLSA
Tiziana Life announces publication of preclinical data in bioRxiv preprint
Premium
The Fly
Tiziana Life announces publication of preclinical data in bioRxiv preprint
4M ago
TLSA
Tiziana Life Sciences Highlights Preclinical Long COVID Brain Fog Data for Intranasal Foralumab
Premium
Company Announcements
Tiziana Life Sciences Highlights Preclinical Long COVID Brain Fog Data for Intranasal Foralumab
4M ago
6K
TLSA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >